Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

383 results found

Article
Ask Lexy

Silk Legal | Thailand | 5 Oct 2021

Innovation is key: BOI announces new Digital Services Platform and Digital Content Category

As part of its efforts to revamp its promotion policies for digital businesses, Thailand’s Board of Investment (BOI) announced on 16 September 2021…
Article
Ask Lexy

DLA Piper | USA | 21 Jun 2021

AI outlook: US Senate approves the US Innovation and Competition Act

The US Senate on Tuesday, June 8, approved the United States Innovation and Competition Act of 2021, comprehensive technology policy and funding…
Article
Ask Lexy

Hogan Lovells | USA | 27 Apr 2021

Biden signs bill limiting new drug exclusivity awards to innovations in active moiety

On April 23, U.S. President Biden signed into law two bills meant to lower prescription drug prices by limiting new drug exclusivity awards and…
Article
Ask Lexy

Bradley Arant Boult Cummings LLP | USA | 16 Apr 2019

Proposed Updates to Alabama Business Tax Laws: Summary of the Financial Institution Excise Tax Reform Act of 2019 and Alabama Innovation Act

Two landmark bills were introduced in the Alabama Legislature on April 11, potentially affecting numerous businesses in the state. Committees of the…
Article
Ask Lexy

Covington & Burling LLP | USA | 11 Mar 2019

Net Neutrality Update: House Hearing and Proposed Legislation

Since the Federal Communications Commission (“FCC”) repealed the 2015 net neutrality rules last year, federal and state lawmakers have debated how to…
Article
Ask Lexy

Mintz | USA | 7 Mar 2019

Device Modernization Series: In Vitro Clinical Tests

In our first two Device Modernization series posts, we discussed FDA’s 510(k) modernization efforts and the proposed De Novo regulation. FDA has also…
Article
Ask Lexy

Seyfarth Shaw LLP | USA | 6 Mar 2019

Biosimilar IPRs: Timing is Everything . . . But When is The Right Time?

Timing the filing of an inter partes review for companies in the early stage of developing a biosimilar product should be carefully considered based…
Article
Ask Lexy

Loeb & Loeb LLP | USA | 28 Feb 2019

FDA Regulatory and Compliance Monthly Recap — February 2019

The guidance outlines the principles for premarket review of combination products and discusses how to determine which type of premarket submission…
Article
Ask Lexy

Cooley LLP | USA | 14 Feb 2019

New bill to exempt low-revenue companies from SOX 404(b)—have we reached an inflection point?

A bipartisan group of Senators has introduced a new bill, the Fostering Innovation Act of 2019 (S. 452), that would amend SOX to provide a temporary…
Article
Ask Lexy

Jones Day | USA | 14 Feb 2019

IPR Appeal Dismissed After Biosimilar Development Discontinued

Article III of the Constitution imposes a “case or controversy” limitation on the jurisdiction of federal courts: an actual case or controversy must…
Previous page 1 2 3 ...